OPTIMIZATION OF RECOMBINANT ANTIBODY PRODUCTION IN CHO CELLS

Recombinant antibody production leverages Chinese hamster ovary (CHO) cells due to their robustness in expressing complex molecules. Optimizing these processes involves adjusting various factors, including cell line engineering, media ingredients, and bioreactor settings. A key goal is to maximize antibody yield while reducing production costs and